Island Pharmaceuticals Ltd Total Liabilities

Latest as of June 2025: AU$336.43K AUD ≈ $238.04K USD

Island Pharmaceuticals Ltd total liabilities. Based on the latest financial reports, Island Pharmaceuticals Ltd (ILA) has total liabilities worth AU$336.43K AUD (≈ $238.04K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Island Pharmaceuticals Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Island Pharmaceuticals Ltd (2019–2024)

Total liabilities of Island Pharmaceuticals Ltd from 2019 to 2024. This chart illustrates how Island Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data.

Island Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Island Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Kyungdong Gas KO:012320	Korea	₩115.39 Billion
Midsummer AB (publ) ST:MIDS	Sweden	Skr313.58 Million
Haulotte Group SA PA:PIG	France	€404.55 Million
NeueHealth Inc NYSE:NEUE	USA	$1.14 Billion
Hwang-Kum Stee KO:032560	Korea	₩110.61 Billion
Stefstock JSE:SSK	South Africa	ZAC5.08 Billion
Guillemot Corporation S.A. PA:GUI	France	€59.05 Million
Empery Digital Inc. NASDAQ:EMPD	USA	$51.74 Million

Liability Composition Analysis (2019–2024)

This chart breaks down Island Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Island Pharmaceuticals Ltd total assets.

Liquidity & Leverage Metrics

Island Pharmaceuticals Ltd Total Liabilities Ratios Explained

Island Pharmaceuticals Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	22.27	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Island Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Island Pharmaceuticals Ltd (2019–2024)

The table below shows the annual total liabilities of Island Pharmaceuticals Ltd from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$336.43K ≈ $238.04K	-67.83%
2023-12-31	AU$1.05 Million ≈ $739.85K	+296.30%
2022-12-31	AU$263.85K ≈ $186.69K	-54.57%
2021-12-31	AU$580.73K ≈ $410.91K	+145.21%
2020-12-31	AU$236.83K ≈ $167.57K	+35037.98%
2019-12-31	AU$674.00 ≈ $476.90	--

About Island Pharmaceuticals Ltd

AU:ILA Australia Biotechnology

Market Cap

$60.92 Million

AU$86.10 Million AUD

Market Cap Rank

#20948 Global

#705 in Australia

Share Price

AU$0.32

Change (1 day)

-1.54%

52-Week Range

AU$0.27 - AU$0.57

All Time High

AU$0.57